Mitochondrial Peptides and Custom Insoles: What the Evidence Actually Shows
Published on 10/11/2026 at 00:41 | Editorial boerse-global.de
Employees in physically demanding jobs have long been promised two very different kinds of relief: molecules that supposedly recharge their cells from within, and footwear engineered to spare their joints from the outside. A closer look at the published material on both fronts reveals a wide gap between what research supports and what marketing claims.
Custom-made shoe inserts and heavily cushioned "active" shoes occupy one end of that spectrum. They aim to correct faulty loading patterns and give orthopaedic support to staff who spend their working day on their feet. Sellers of the cushioned models go further, advertising noticeable relief from joint, back and heel pain. Specialists counter that promises of immediate, complete freedom from symptoms rest almost entirely on statements from manufacturers and retailers, with little backing from independent studies.
Newer products such as vibrating insoles, which test reports suggest may improve balance, point to interesting sensory possibilities. Whether they deliver lasting benefits in day-to-day work still has to be demonstrated.
The Mitochondrial Angle
At the other end sit biochemical approaches built around mitochondria, the power plants of the cell — which is precisely why anything that tinkers with their metabolism attracts attention.
Take MOTS-c. Articles on the peptide claim it can stimulate glucose uptake and energy production in muscle cells via the enzyme AMPK, feeding expectations of greater endurance, higher resilience under load and faster recovery after exertion. Those assumptions, however, tend to rest on theoretical mechanisms. Reliable long-term data on efficacy and safety in humans is still missing.
SS-31 follows a similar pattern. The mitochondrial tetrapeptide, also known in the literature as elamipretide, Bendavia or MTP-131, shows a binding affinity for cardiolipin, a key lipid of the inner mitochondrial membrane. Individual accounts describe subjective effects on recovery or an initial bout of fatigue, yet such feedback lacks robust clinical evidence.
In experimental research settings, dosage ranges of 4 to 40 milligrams are described — protocols that are by no means generally established as reliable. Oral intake is ruled out in research anyway, since the active substance is broken down in the gastrointestinal tract.
Urolithin A and the Microbiome
A third piece in the mitochondrial puzzle is Urolithin A, a metabolite produced by gut bacteria when the body processes so-called ellagitannins from foods such as pomegranates, berries and nuts. It is credited with promoting mitophagy — the breakdown of damaged mitochondria — and thereby supporting cellular function.
Claims about greater muscle strength, more vitality and anti-aging effects, though, are frequently presented without concrete clinical evidence and are sometimes closely tied to advertising for Urolithin A powders.
Ergonomic measures in the workplace act far more directly than experimental biochemical substances. Tailored insoles are designed to offset improper loading and provide orthopaedic support for employees who must stand or walk for long stretches of their working day. That, at least, is a benefit workers can evaluate on their own two feet.
